Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) Program

Publication date: Available online 3 November 2018

Source: Journal of the American Academy of Dermatology

Author(s): Ryan C. Kelm, Erika L. Hagstrom, Regine J. Mathieu, Kelsey A. Orrell, Linda Serrano, Kelly A. Mueller, Anne E. Laumann, Dennis P. West, Beatrice Nardone

https://ift.tt/2zpvzuT